HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer.

AbstractINTRODUCTION:
Toll-like receptors (TLRs) are a family of pattern recognition receptors that are expressed on cells of the innate immune system. The ligands can be pathogen derived (pathogen associated molecular patterns; PAMPs) or endogenous (damage associated molecular patterns; DAMPs) that when bound induces activation of nuclear factor kappa B (NF-κB) and transcription of pro-inflammatory genes. TLRs have also been discovered in various malignant cell types, but with unknown function.
METHODS:
In this study we performed a detailed analysis of TLR and co-receptor expression pattern and function in breast cancer. Expression patterns were examined using real-time quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry (IHC) on three estrogen receptor-positive (ER(+)) and four estrogen receptor/progesterone receptor-negative (ER(-)/PR(-); ER/PR-negative) breast cancer cell lines, and a breast cancer cohort consisting of 144 primary breast cancer samples. The function was investigated using in vitro assays comprising PAMP/DAMP-stimulation, downstream signaling and TLR-silencing experiments.
RESULTS:
We found that TLR4 was expressed in a biologically active form and responded to both PAMPs and DAMPs primarily in ER/PR-negative breast cancers. Stimulation of TLR2/4 in vitro induced expression of pro-inflammatory genes and a gene expression analysis of primary breast cancers showed a strong correlation between TLR4 expression and expression of pro-inflammatory mediators. In line with this, TLR4 protein expression correlated with a decreased survival.
CONCLUSIONS:
These findings suggest that TLR4 is expressed in a functional form in ER/PR-negative breast cancers. Studies regarding TLR4-antagonist therapies should be focusing on ER/PR-negative breast cancer particularly.
AuthorsMeliha Mehmeti, Roni Allaoui, Caroline Bergenfelz, Lao H Saal, Stephen P Ethier, Martin E Johansson, Karin Jirström, Karin Leandersson
JournalBreast cancer research : BCR (Breast Cancer Res) Vol. 17 Pg. 130 (Sep 22 2015) ISSN: 1465-542X [Electronic] England
PMID26392082 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • NF-kappa B
  • Receptors, Estrogen
  • Receptors, Progesterone
  • TLR2 protein, human
  • TLR4 protein, human
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
Topics
  • Breast Neoplasms (genetics)
  • Cell Line, Tumor
  • Female
  • Gene Expression (genetics)
  • Humans
  • MCF-7 Cells
  • NF-kappa B (genetics)
  • Receptors, Estrogen (genetics)
  • Receptors, Progesterone (genetics)
  • Signal Transduction (genetics)
  • Toll-Like Receptor 2 (genetics)
  • Toll-Like Receptor 4 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: